Skip to content

Clinical trials

Completed Parkinson Disease trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Status: Completed Country / region: Switzerland Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20063
20092
20111
20124
20131
20143
20151
20164
20181
20191
20202
20215
20221
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
University Hospital, Basel, Switzerland3
AbbVie2
Bial - Portela C S.A.2
Christian Baumann2
Insel Gruppe AG, University Hospital Bern2
Luzerner Kantonsspital2
Neurocenter of Southern Switzerland2
UCB Pharma2
Aleva Neurotherapeutics SA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease34
Dyskinesias4
Movement Disorders3
Dysarthria2
Essential Tremor2
Parkinsonian Disorders2
Cardiovascular Diseases1
Cerebral Palsy1
Cognitive Dysfunction1
Disorders of Excessive Somnolence1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.